Covered recipient · General Payments record
MARISSA J QUIRK
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$1,189.81
- Reported across 80 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $727.28 | 54 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $275.03 | 18 |
| PFIZER INC. | $147.22 | 18 |
| Novo Nordisk AS | $104.34 | 6 |
| Lilly USA, LLC | $53.76 | 3 |
| Exact Sciences Corporation | $41.82 | 3 |
| SHIELD THERAPEUTICS INC | $29.92 | 2 |
| Gilead Sciences, Inc. | $22.35 | 1 |
| Amgen Inc. | $21.47 | 1 |
| Acerta Pharma LLC | $15.84 | 1 |
| Currax Pharmaceuticals LLC | $15.53 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (54)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.20 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108050731 | CMS |
| ABBVIE INC. | $19.42 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108050733 | CMS |
| ABBVIE INC. | $28.54 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108050735 | CMS |
| ABBVIE INC. | $8.99 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108050737 | CMS |
| ABBVIE INC. | $13.93 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108050739 | CMS |
| ABBVIE INC. | $14.10 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108050741 | CMS |
| ABBVIE INC. | $14.67 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108050743 | CMS |
| ABBVIE INC. | $4.01 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108050745 | CMS |
| ABBVIE INC. | $24.62 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108050747 | CMS |
| ABBVIE INC. | $10.08 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108050749 | CMS |
| ABBVIE INC. | $26.68 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108050751 | CMS |
| ABBVIE INC. | $11.17 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108050753 | CMS |
| ABBVIE INC. | $5.83 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108050755 | CMS |
| ABBVIE INC. | $10.74 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108050757 | CMS |
| ABBVIE INC. | $14.15 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108050759 | CMS |
| ABBVIE INC. | $10.52 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108050761 | CMS |
| ABBVIE INC. | $14.70 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108050763 | CMS |
| ABBVIE INC. | $19.68 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108050765 | CMS |
| Amgen Inc. | $21.47 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117660656 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.84 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104503600 | CMS |
| Currax Pharmaceuticals LLC | $15.53 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089523783 | CMS |
| Exact Sciences Corporation | $15.38 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114473107 | CMS |
| Exact Sciences Corporation | $13.08 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114473112 | CMS |
| Exact Sciences Corporation | $13.36 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114473118 | CMS |
| Gilead Sciences, Inc. | $22.35 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133665732 | CMS |
| Lilly USA, LLC | $14.63 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135814385 | CMS |
| Lilly USA, LLC | $24.70 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135755701 | CMS |
| Lilly USA, LLC | $14.43 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135806645 | CMS |
| Novo Nordisk Inc | $15.58 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100537716 | CMS |
| Novo Nordisk Inc | $17.67 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100485037 | CMS |
| Novo Nordisk Inc | $15.66 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100373276 | CMS |
| Novo Nordisk Inc | $24.68 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100247644 | CMS |
| Novo Nordisk Inc | $13.96 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100388341 | CMS |
| Novo Nordisk Inc | $16.79 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100331666 | CMS |
| PFIZER INC. | $10.30 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130883118 | CMS |
| PFIZER INC. | $11.14 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130883482 | CMS |
| PFIZER INC. | $4.39 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130883480 | CMS |
| PFIZER INC. | $4.85 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130883120 | CMS |
| PFIZER INC. | $10.72 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130883484 | CMS |
| PFIZER INC. | $5.65 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132049036 | CMS |
| PFIZER INC. | $5.97 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132049482 | CMS |
| PFIZER INC. | $3.01 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132044712 | CMS |
| PFIZER INC. | $2.32 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132054632 | CMS |
| PFIZER INC. | $7.49 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132054344 | CMS |
| PFIZER INC. | $13.66 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131775567 | CMS |
| PFIZER INC. | $7.65 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132057298 | CMS |
| PFIZER INC. | $5.80 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132067873 | CMS |
| PFIZER INC. | $6.08 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132102311 | CMS |
| PFIZER INC. | $6.01 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130881664 | CMS |
| PFIZER INC. | $19.91 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132070791 | CMS |
| PFIZER INC. | $5.98 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132123182 | CMS |
| PFIZER INC. | $16.29 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131479443 | CMS |
| SHIELD THERAPEUTICS INC | $15.29 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150145486 | CMS |
| SHIELD THERAPEUTICS INC | $14.63 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150158070 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.